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ABSTRACT
Neural tube defect (NTD) is a multi-factorial disorder in which nutritional, genetic and environmental 
factors are involved. Among the nutritional factors, low level of serum zinc has been reported from differ-
ent parts of the world. This hospital-based case-control study was conducted with the objective of finding 
the relationship between serum zinc level in newborns and their mothers and NTDs in a Bangladeshi 
population. The study was conducted during August 2006–July 2007 at the Bangabandhu Sheikh Mujib 
Medical University (BSMMU) in Dhaka. In total, 32 mothers and their newborns with NTDs were included 
as cases and another 32 mothers with their normal babies were included as controls. Concentration of se-
rum zinc was determined by pyro-coated graphite furnace atomic absorption spectrophotometer (GF-AAS). 
The mean age of the case and control mothers was 25.28 years and 24.34 years respectively. The mean 
gestational age of the case newborns was 36.59 weeks and that of the control newborns was 37.75 weeks. 
The mean serum zinc level of the case and control mothers was 610.2 µg/L and 883.0 µg/L respectively 
(p<0.01). The mean serum zinc level of the case and control newborns was 723 µg/L and 1,046 µg/L respec-
tively (p<0.01). In both case and control groups, the serum zinc level of the newborns positively correlated 
with that of the mothers. The serum zinc levels of the mothers and newborns negatively correlated with 
NTDs. Mothers with serum zinc level lower than normal were 7.66 [95% confidence interval (CI) 2.5-23.28] 
times more likely to have NTDs compared to the normal zinc level of mothers. After adjusting for the zinc 
level of the newborns, parity, and age of the mothers, this risk reduced 1.61 times [confidence interval 
(CI) 95% 0.24-8.77]. On the other hand, the low serum zinc level of the newborns was 7.22 times more 
associated with NTDs compared to the newborns with the normal serum zinc level, which was statistically 
significant (p=0.001). After adjusting for other factors, such as maternal age and parity, newborns with the 
low serum zinc level was found to be 9.186 times more likely to be associated with NTDs compared to new-
borns with normal serum zinc level. Based on the findings, it may be concluded that the low serum zinc 
levels of newborns may be associated with NTDs. To confirm these findings, a further study with a larger 
sample-size is recommended. Moreover, a follow-up study with zinc supplementation to pregnant women 
and its impact on NTDs is also recommended.
Key words: Atomic absorption spectrophotometer; Case-control studies; Neural tube defects; Serum zinc; 
Zinc deficiency; Bangladesh
Correspondence and reprint requests should be 
addressed to:
Dr. Arjun Chandra Dey
Assistant Professor
Department of Neonatology
Bangabandhu Sheikh Mujib Medical University
Shahbagh, Dhaka 1000
Bangladesh
Email: acd_70@yahoo.com 
Fax: 88-02-9668647
INTRODUCTION
Neural tube defects (NTDs) account for most con-
genital anomalies of the central nervous system 
(CNS). NTDs are a group of very serious birth-de-
fects that arise when the neural tube fails to devel-
op into the brain and spinal cord during the first 
month of pregnancy. 
The CNS appears at the beginning of the third week 
of pregnancy as a slipper-shaped plate of thick-
ened ectoderm—the neural plate—in the mid-
dorsal region in front of the primitive node. Its lat-
eral edges soon elevate to form the neural folds (1). 
The neural folds elevate, approximate each other, 
and finally close to form the neural tube.Dey AC et al. Serum zinc and neural tube defects
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The nutritional status of pregnant women may 
influence the vulnerability to NTDs in the foetus. 
Folate deficiency is a well-known cause of NTDs. 
The search for other aetiological factors, particu-
larly nutritional factors, has been continuing. In 
recent years, zinc and vitamin B12 have attracted 
the attention of researchers in relation to the devel-
opment of NTD. 
Zinc is essential for the growth and development 
of the foetus and plays a critical role in many cellu-
lar reactions, including gene transcription and cell 
division and differentiation. The inadequate intake 
of zinc is associated with NTDs in both animals 
and humans (2). The essentiality of zinc in the for-
mation of neural tube is further supported by the 
observation that women with acrodermatitis en-
teropathica, a disorder of impaired zinc absorption 
from the intestine, are at high risk for babies with 
NTDs (3), although the possible mechanism is not 
known. Women with second trimester-induced 
abortion, resulting from NTDs, have a significant 
low level of serum zinc and selenium (4). Authors 
of several studies recommended supplementation 
of zinc, in addition to folic acid, for the further de-
crease in the recurrence and occurrence of NTDs (2-
4). However, others found increased zinc content 
in umbilical cord serum in anencephalic newborns 
and spina bifida-affected newborns (5). Simultane-
ously in mothers having babies with NTD, total 
serum zinc was similar to controls but there was a 
shift in the distribution of zinc from alpha-2 mac-
roglobulin to albumin. Foetal hyperzincaemia and 
elevated maternal albumin-bound zinc found in 
the study suggest that the NTD-foetus receives zinc 
but does not normally uses it.
Newborns with NTDs have a significantly low level 
of serum zinc, supporting zinc deficiency as an as-
sociation of NTDs (6,7). Zeyrek et al. reported that 
low maternal zinc and high copper during preg-
nancy may be responsible for NTDs (8). 
The worldwide incidence of NTDs is estimated to 
be around 1 per 1,000 livebirths (9). However, there 
are remarkable variations in the incidence of NTDs 
and other CNS defects. In certain regions of China, 
the incidence of NTD is 1 in 100 livebirths, be-
ing the highest (10) whereas, in the Scandinavian 
countries, it is only 1 in 5,000 livebirths (7). In the 
United States, the incidence of NTDs was estimated 
at 1 per 1,000 deliveries, anencephaly at 0.6-0.8 per 
1,000 livebirths, and open spina bifida as 0.5-0.8 
per 1,000 livebirths (11). No data are available on 
the incidence and prevalence of NTDs in Bangla-
desh, although this malformation is fairly common 
in the clinical practices.
This study was designed to see the correlation of 
NTDs with maternal and newborn serum zinc con-
comitantly.
MATERIALS AND METHODS 
This case-control study was conducted at the De-
partment of Neonatology, Bangabandhu Sheikh 
Mujib Medical University (BSMMU) Hospital in 
Dhaka, during August 2006–July 2007. Cases were 
selected from the Departments of Neonatology, Ob-
stetrics-Gynaecology, and Neurosurgery, BSMMU, 
Dhaka Medical College Hospital (DMCH), and Ma-
ternal and Child Health Training Institute (MCHTI), 
Azimpur, Dhaka.
Of the three hospitals, the BSMMU primarily deals 
with cases referred from all over the country, which 
logically is not representative of the general popu- 
lation. The DMCH is more easily accessible for 
the general people from all over the country and, 
hence, is representative of the population. The 
MCHTI, a referral centre for obstetric patients, con-
ducts a good number of deliveries per year. 
NTDs were diagnosed on ultrasonography in the 
later weeks of pregnancy and passively on referral 
after birth. Alpha fetoprotein level, a good indica-
tor of NTD, was not assayed as most mothers were 
not capable financially, and this is also not an easi- 
ly-available investigation in the country. 
Study population 
Newborn babies with NTDs and their mothers 
were considered cases whereas normal babies and 
their mothers were included as controls. The study 
excluded mothers taking zinc supplement during 
anytime of pregnancy and newborn babies with 
other major congenital anomalies and syndrome 
in babies where NTD is a component, e.g. Meckel 
Gruber syndrome. Controls were randomly select-
ed. Blood samples were drawn from the mothers 
and their babies within one week after delivery.
Sample-size
The sample-size was calculated using the following 
formula:
n=
 z2pq     
       e2
where z=1.96, p=1 (worldwide incidence 1 in 
1,000 livebirths, q=100-p, e=5, acceptable error).
The formula dictates that the sample-size for 
the study would be around 15. However, given 
the one-year timeframe of the study (the study Dey AC et al. Serum zinc and neural tube defects
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was done as a thesis for MD in neonatology) and 
also availability of cases in the three hospitals, the 
sample-size was fixed at 30. During the study pe-
riod, two more cases met the inclusion criteria. 
Therefore, in total, 32 cases (mothers and babies 
with NTDs) were enrolled. However, two newborns 
with anencephaly were stillborn, and one died im-
mediately after birth. As the serum zinc of those 
three newborns could not be measured, serum zinc 
was measured in 29 pairs of mother and baby and 
three mothers without babies. Controls were limit-
ed to 32 pairs mainly due to financial constraints.
Data-collection method
A preformed data-collection sheet was used for 
collecting data. Baseline information was col-
lected from cases who agreed to participate in 
the study. Body mass index (BMI) of the moth-
ers was recorded. Emphasis was given on mea-
suring the occipito-frontal circumference while 
examining the newborn with NTD to exclude 
the possible association of hydrocephalus. 
Biochemical analysis
Plastic wares, free of metallic contamination, es-
pecially zinc, were used for collecting blood speci-
mens. The plastic wares were kept immersed in 
detergent water at least for half an hour, washed 
thoroughly with running water, and allowed to dry 
in air. The plastic wares were then kept immersed 
for 24 hours in 20% nitric acid. After 24 hours, all 
the equipment were washed three times in de-ion-
ized water and were air-dried. The air-dried con-
tainers were stored in a capped plastic container, to 
be used later in sample collection. Using a dispos-
able plastic syringe, taking aseptic precautions, 5 
mL of venous blood was collected from the moth-
ers and newborns within seven days after deliv-
ery. It was then transferred to a de-ionized plastic 
test-tube. Blood was centrifuged at 3,500 rpm for 
five minutes, and the serum was transferred to 
a clean polypropylene tube. The sample was 
then frozen at -35 °C for long-term storage until 
assay for zinc concentrations was done. Serum zinc 
was estimated in the Department of Biochemistry, 
BSMMU, using graphite furnace atomic absorption 
spectrophotometer (GF-AAS, 6650 Shimadzu). The 
level of serum zinc was expressed in µg/L. 
Statistical analyses
Data were analyzed using the SPSS software for Win-
dows (version 13.0) (SPSS Inc., Chicago, IL). Chi-
square test was used for comparing proportions. 
Student’s unpaired t-test was applied for testing the 
differences between continuous variables. Cross-
tabulation and multivariate analyses were used for 
exposing the associations between the dependent 
and the independent variables. A two-sided p value 
of <0.05 was considered significant at 95% level. 
Pearson’s correlation test was used for seeing the 
correlation between continuous variables. Howev-
er, the comparison between a quantitative variable 
and a qualitative variable was made with the help 
of Point biserial correlation.
Ethics
Before the study, permission was taken from the 
Chairmen and Department Heads of the respec-
tive institutions. The Ethical Committee of the 
Department of Paediatrics, BSMMU, approved the 
protocol. Finally, informed written consent was 
taken from all the mothers/parents/guardians af-
ter full explanations of the nature and purpose of 
the procedure used for the study. Anonymity was 
maintained throughout the study, and none of the 
names was used in the database.
RESULTS
In the one-year study period in the DMCH, 10,861 
deliveries were conducted, of which 16 cases (0.1%) 
had NTDs. Of 5,778 deliveries in the BSMMU, 11 
cases (0.2%) had NTDs, and of 3,628 deliveries in 
the MCHTI, Azimpur, one case had NTD. The inci-
dence of NTDs, on average, was 1.3 per 1,000 live-
births. Four cases were delivered either in the home 
or in other hospitals and were later referred to one 
of these hospitals. 
Table 1 shows the baseline characteristics of the 
affected mothers. Age, BMI, occupation, socioeco-
nomic condition, and status of antenatal check-
ups were compared between the case and the 
control mothers but no significant difference was 
observed. 
The mean±standard deviation (SD) parity of the 
mothers of newborns with and without NTDs was 
2.2±1.1 and 1.5±0.8 respectively. The difference 
was significant (p<0.01). The mean±SD gestational 
age at delivery of the cases was 36.6±1.8 weeks and 
that of the controls was 37.8±1.2 weeks. The differ-
ence was significant (p<0.01).
The large majority (75%) of the case mothers deliv-
ered their NTD-affected babies per vagina whereas 
the caesarian section rate was higher among the 
controls. The difference was significant (p<0.05).
Various types of NTDs were observed among the 
study subjects (Table 2). Of the 32 cases, 20 were Dey AC et al. Serum zinc and neural tube defects
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meningomyelocele (62.5%), followed by enceph-
alocele (n=7, 21.8%), anencephaly (n=3, 9.4%), 
and others (n=2, 6.2%). Eighty-five percent of the 
meningomyelocele cases were associated with hy-
drocephalus. 
The mean±SD concentration of maternal serum 
zinc level in the case group was 610.2±53.1 µg/L 
and that in the control group was 883.0±65.2 µg/L 
(Table 3). The difference was significant (p<0.01) 
between the two groups. The mean±SD serum zinc 
level of the newborns in the cases and controls was 
723.0±56.3 and 1,046.0±56.3 µg/L respectively (Ta-
ble 3). The difference was significant (p<0.01).
The maternal and newborn serum zinc levels posi-
tively correlated with each other (R=0.976, p<0.05), 
which means that the serum level of the mothers 
and newborns in both case and control groups had 
a linear relationship (Fig. 1 and 2).
The results showed a negative correlation between 
maternal serum zinc level and NTDs (Fig. 3). Simi-
Table 1. Variables analyzed in the study
Variable Case Control p value
Age (years) of mothers (mean±SD) 25.3±6.1 24.3±5.03 0.505
Age-group (years) of mothers (%)
   17-24 
   25-32 
   33-40
56.3
31.3
12.5
65.6
25.0
09.4
BMI (mean±SD) 21.8±2.3 22.7±3.2 0.168
Occupation of mothers 
   Housewife, no. (%)
   Employed, no.  (%)
32 (100)
0 (0)
30 (93.8)
2 (6.3)
0.472
Socioeconomic status   
   Middle*, no. (%)
   Lower†, no. (%)
13 (40.6)
19 (59.4)
11(34.4)
21 (65.6)
0.565
Parity of mothers (mean±SD) 2.2±1.1 1.5±0.8 0.007
Antenatal check-up
   Regular$, no. (%)
   Irregular§, no. (%)
   None (%)
14 (43.7)
8 (25.0)
10 (31.3)
8 (25.0)
5 (15.6)
19 (59.4)
0.077
Gestational age at delivery (mean±SD) 36.6±1.8 37.8±1.2 0.004
Mode of delivery  
   Vaginal delivary, no. (%)
   Caesarean section, no. (%)
24 (75.0)
8 (25.0)
15 (46.9)
17 (53.1)
0.021
Volume of liquor 
   Normal
   High
29 (90.6)
3 (9.4)
32 (100)
0 (0.0) 0.237
The p value is significant if <0.05; *Middle class was categorized arbitrarily based on family income 
(Tk 10,000-20,000 per month); †Lower class was categorized arbitrarily based on family income (<Tk 
10,000 per month); $At least 3 visits during pregnancy; §Irregular antenatal check-up: less than 3 visits 
during pregnancy; BMI=Body mass index; SD=Standard deviation
Table 2. Types of NTD among cases studied (n=32)
Type of NTD No. of cases %
Associated hydrocephalus
No. %
Meningomyelocele 20 62. 5 17 85.0
Encephalocele 7 21.9 0 0
Anencephaly 3 9.4 0 0
Meningocele  1 3.1 0 0
Lipomeningocele 1 3.1 0 0
Total 32 100 17 53.1
NTD=Neural tube defectDey AC et al. Serum zinc and neural tube defects
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larly, a negative correlation was also observed be-
tween the serum zinc level of the newborns and 
NTDs (Fig. 4). This means that the newborn babies 
4) were analyzed as risk factors of NTDs (Table 4). 
Model 1 showed that the unadjusted odds ratios, 
i.e. mothers with low serum zinc level (<700 
2,000 1,500 1,000 500
Serum zinc level (µg/L) of mothers (n=29) 
2,000
1,500
1,000
500
Pearson correlation=0.976
p<0.05
S
e
r
u
m
 
z
i
n
c
 
l
e
v
e
l
 
(
µ
g
/
L
)
 
o
f
n
e
w
b
o
r
n
s
 
(
n
=
2
9
)
Fig. 1. Correlation of serum zinc level of control 
mother and newborns
Fig. 2. Correlation of serum zinc level of case
  mothers and newborns
Serum zinc level (µg/L) of mothers (n=29) 
Pearson correlation=0.976
p<0.05
S
e
r
u
m
 
z
i
n
c
 
l
e
v
e
l
 
(
µ
g
/
L
)
 
o
f
 
n
e
w
b
o
r
n
s
 
(
n
=
3
2
)
1,500 1,000 500 0
1,750
1,500
1,250
1,000
750
500
250
with the highest level of serum zinc had the lowest 
number of NTDs and vice versa. This correlation 
was significant. 
Multiple logistic regression analysis was done 
where different variables, such as maternal zinc 
level (Model 1), neonatal zinc level (Model 2), ma-
ternal parity (Model 3), and maternal age (Model 
Fig. 3. Correlation between maternal serum zinc
  level and neural tube defects  
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Fig. 4. Correlation between newborn serum zinc 
  level and neural tube defects
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µg/L), were significantly associated with NTD-
affected babies [odds ratio (OR)=7.7, 95% confi-
dence interval (CI) 2.5-23.3]. Model 2 showed that 
the newborns with the low serum zinc level were 
strongly associated with NTDs compared to those 
who had normal serum zinc (OR=7.2, 95% CI 1.4-
38.74). It was observed in Model 3 that multiparity 
Table 3. Serum zinc level of mothers and newborns in case and control groups
Group
            Zinc level (µg/L)
p value
Mean±SD Range
Mothers
Case (n=32)
Control (n=32)
610.2±53.1
883.0±65.2
135.0-1,610.0    
435.0-1,912.0                
0.002
Newborns
0.001 Case (n=29) 723.0±56.3 345.0-1,710.0      
Control (n=32) 1,046.0±56.3 621.0-2,014.0     
SD=Standard deviationDey AC et al. Serum zinc and neural tube defects
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had no significant relationship with NTDs, and it 
slightly lowered the level of significance of the 
impact of the newborn zinc level on NTDs. Mater-
nal age had no significant effect on NTDs but, after 
adjusting for maternal age and parity, the impact 
of the newborn zinc level on NTDs became higher 
(OR=9.2, 95% CI 1.5-56.9). This means that, after 
adjusting for other variables, the newborns with 
the low serum level were significantly (p<0.05) as-
sociated with the occurrence of NTDs. 
DISCUSSION
Our study found that the mean age of the case 
mothers was 25.3 years and that of the control 
group was 24.3 years, which was comparable with 
the mean age of mothers in a study in Iran (7). It 
was found in another study that the incidence of 
NTDs decreased with increased maternal age (12). 
On the other hand, a U-shaped distribution of 
NTDs in relation to age has been described (13,14). 
Our study did not find any correlation of this kind, 
which may be attributable to the relatively smaller 
sample-size. 
Higher parity was an important factor relating to 
NTDs in the present study as the multipara moth-
ers were affected significantly more than the pri-
mipara mothers. Literature suggests a variable pat-
tern of findings. Results of a meta-analysis showed 
that pregnancy with higher parity was more likely 
to have a spina bifida defect than with lower par-
ity (15). On the other hand, a striking contrast was 
also observed where risk of spina bifida decreased 
with parity (16).
In the present study, the mean gestational age of 
the case group was 36.6 weeks whereas that of the 
control group was 37.8 weeks. This finding corre-
lates with the well-established fact that any con-
genital malformation in the foetus may lead to 
preterm delivery. NTD is particularly known to be 
associated with preterm delivery (16). 
Anencephaly is a well-known cause of polyhydram-
nios (17,18). In our study, three cases of anenceph-
aly were associated with polyhydramnios. 
Worldwide, meningomyelocele is most common 
among NTDs and is associated with hydrocepha-
lus in more than 85% of cases. Results of studies 
showed that meningomyelocele contributed 86.8% 
of spina bifida cystica cases (11,19), which is consis-
tent with the findings of the present study. In the 
present study, about 63% of the NTDs were menin-
gomyelocele, of which 85% were associated with 
hydrocephalus.
The results of the present study showed that mater-
nal zinc deficiency was associated with NTDs. Some 
studies found a similar correlation between zinc 
deficiency and NTDs (6,20). Zeyrek et al. reported 
a maternal low serum zinc level and a high cop-
per level as an association with NTDs (8). A recent 
study in Iran reported maternal zinc deficiency to 
be associated with NTDs (21). However, results of 
some studies also suggest that zinc deficiency was 
not related to NTDs (22,23), although population-
based case-control studies concluded that the risk 
of NTDs in infants and foetuses decreased with in-
creasing maternal zinc intake (24,25).
The NTD-affected newborns had a lower level of 
serum zinc (mean 723 μg/L) compared to the un-
affected newborns (mean 1,046 μg/L), suggesting 
that zinc deficiency is associated with NTDs. The as-
Table 4. Logistic regression analysis of variables
Indicator
Model 1 Model 2 Model 3 Model 4
Unadjusted
OR (CI)
Adjusted OR (CI) Adjusted OR (CI) Adjusted OR (CI)
Zinc level of mothers
>700† (0-700) 7.7* (2.5-23.3) 1.9 (0.4-9.8) 1.9 (0.3-9.9) 1.6 (0.3-8.6)
Zinc level of newborns  
>700† (0-700) 7.2* (1.3-38.7) 6.8* (1.2-37.0) 9.2* (1.5-56.9)
Multiparity
   Primi† 
   Multipara
1.6 (0.19-12.4) 1.5 (0.1-25.8)
Age (years)
   17-24†
   25-33
   34-40
2.1 (0.51-5.8)
0.9 (0.1-12.4)
†Reference category; *Significant (p<0.05); CI=Confidence interval; OR=Odds ratioDey AC et al. Serum zinc and neural tube defects
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sociation of the lowest serum zinc in the newborns 
and NDTs is quite consistent with that of a study in 
Iran (7). Results of a study in Turkey showed new-
born serum zinc and selenium to be low in NTDs 
compared to normal controls (26). An Indian study 
that evaluated maternal and newborn hair zinc lev-
els in association with NTDs found that the hair 
zinc levels in both mothers and newborns were 
significantly low compared to normal controls and 
recommended a follow-up study with zinc supple-
mentation in the periconceptional period and out-
come in the subsequent pregnancy (27). 
Multiple logistic regression analysis in our study re-
vealed that an unadjusted maternal low zinc level 
was associated with NTDs but it was negatively 
confounded by other variables, such as serum zinc 
level of newborns, age of mothers, and parity. The 
low serum zinc levels of the newborns were sig-
nificantly associated with NTDs compared to those 
having the normal serum zinc levels. When adjust-
ed with age of mother and parity, the low serum 
zinc level of the newborns was more significantly 
associated with NTDs.
Limitations
The sample-size in the study was small, and blood 
samples from the newborns were drawn within one 
week, not immediately after birth, which would 
have generated a better understanding about the 
serum zinc status of the newborns. Moreover, some 
other known risk factors, such as diabetes mellitus 
and exposure to arsenic, were not considered while 
selecting the cases. The serum zinc level of the 
mothers during the first trimester was not known 
which is crucial for the development of NTDs. 
Moreover, it was not known whether the zinc level 
after birth was reflective of that in the first trimes-
ter. As NTD is an uncommon disorder, the findings 
of the present study would be more valid if the con-
trol sample-size was a larger one. 
Conclusions
The results of the present study suggest, among the 
factors evaluated, that the low serum zinc level in 
newborns is significantly associated with NTDs. 
The low level of maternal serum zinc seemed to 
be associated but it was confounded negatively by 
other variables. 
A further study with a larger sample-size and a 
control from the representative group of popula-
tion would yield a more acceptable finding in this 
regard. Moreover, a randomized trial with pericon-
ceptional zinc supplementation and its impact on 
subsequent pregnancy with respect to NTDs may 
generate more conclusive evidence of the relation-
ship between the serum zinc level and NTDs.
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